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Background: Conventional reoperative mitral valve surgery by median sternotomy has several difficulties. We
performed mitral valve replacement (MVR) under ventricular fibrillation (VF) through right mini-thoracotomy with
three-dimensional videoscope for avoiding the problems.
Methods: Between 2006 and 2011, we performed 257 cases of MVR, in which 125 cases underwent isolated MVR.
Ten cases of patients underwent reoperative MVR under VF through thoracotomy with three-dimensional videoscope
(Group I), and 27 cases of patients underwent reoperative conventional MVR through median sternotomy (Group II). We
retrospectively reviewed the outcomes and compared Group I with Group II. Preoperative left ventricular ejection
fraction (LVEF) was significantly lower (50.5 ± 19.8% vs 64.4 ± 12.0%; p = 0.046), and significantly higher Euro SCORE was
found in Group I (4.8 ± 2.0 vs 3.8 ± 2.4; p = 0.037).
Results: Although Group I required cooling and rewarming time, average operative times was significantly shorter in
Group I (262 ± 46 min vs 300 ± 57 min; p = 0.044), and cardiopulmonary bypass times and average VF times in Group I
and aortic cross-clamp times in Group II were equivalent. There was no significant difference in the average of
postoperative maximum creatine kinase (CK)-MB. In-hospital mortality was 0/10 (0%) and 1/27 (3.7%), and postoperative
paravalvular leakage occurred in 0/10 (0%) and 1/27 (3.7%), and stroke occurred in 1/10 (10%) and 1/27 (3.7%) for
Groups I and II. Two patients underwent reoperation for bleeding in Group II. Intensive care unit stay in Group I was
significantly shorter than in Group II (1.8 ± 0.6 days vs 3.0 ± 1.7 days; p = 0.025).
Conclusions: The higher risk of preoperative background in Group I had no effect on the operation. Mitral valve
surgery under VF through right mini-thoracotomy can be an alternative procedure for reoperation after conventional
various cardiothoracic surgeries.Background
Conventional reoperative mitral valve replacement
(MVR) has several challenges and difficulties in the dis-
section of broad adhesions to the apex, prevention of in-
jury of the bypassed graft and right ventricle, aortic
clamp and myocardial protection. The right thoracotomy
approach under ventricular fibrillation (VF) can avoid all
these problems [1-3]. Reoperative mitral valve surgery
through right thoracotomy has been demonstrated to be
safe with similar results to sternotomy [4-6]. We intro-
duced twin-lens three-dimensional videoscope (Shinko
Optical CoLtd, Tokyo, Japan) into this procedure to* Correspondence: bassbord1028@yahoo.co.jp
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reproduction in any medium, provided the orobtain more clear view and accurate operation. Our
study retrospectively analyzes an institutional experience
with reoperative MVR under VF through right mini-
thoracotomy using a three-dimensional videoscope
(including previously reported one case) [7].
Methods
From January 2006 through September 2011, 257 pa-
tients underwent MVR at the Sakakibara Heart Insti-
tute of Okayama. Isolated MVR (including tricuspid
valve annuloplasty) was performed in 125 patients
and 132 patients underwent concomitant procedures.
In the isolated MVR cases, 10 cases were non-clamp
reoperative MVR via right mini-thoracotomy under
VF using three-dimensional videoscope, 27 cases wereLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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under cardiac arrest, 20 cases were initial MVR via
right mini-thoracotomy under cardiac arrest, 64 cases
were initial conventional MVR via sternotomy under
cardiac arrest and 4 cases were patients who had initial
MVR via partial sternotomy under cardiac arrest. We
reviewed this non-clamp reoperative MVR (Group I:
n = 10), and compared the outcomes with conven-
tional reoperative MVR through median sternotomy
(Group II: n = 27). Table 1 shows the data of cases and
patient characteristics. For the routine preoperative
evaluation, all patients underwent chest X-ray, echocar-
diography, coronary angiography, bilateral carotid ar-
tery ultrasonography, computed tomography, magnetic
resonance imaging in head and neck, and ankle-
brachial index assessments. As a general rule, we se-
lected the conventional reoperative MVR through
seternotomy. We adopted the non-clamp reoperative






Age (years) 68.0 ± 15.0 62.8 ± 15.3 0.217
Female 5 (50.0%) 9 (33.3%) 0.454
BSA (m2) 1.54 ± 0.29 1.57 ± 0.18 0.411
LVEF (%) 50.5 ± 19.8 64.4 ± 12.0 0.046
PAP (mmHg) 37.1 ± 13.7 42.9 ± 13.9 0.255
LVDd (mm) 57.0 ± 8.7 48.2 ± 6.7 0.009
LVDs (mm) 42.3 ± 15.2 30.6 ± 5.9 0.009
LAD (mm) 46.5 ± 9.3 50.2 ± 11.9 0.339
MR (0–4) 3.9 ± 0.2 3.1 ± 1.1 0.046
AF 3 (30.0%) 11 (40.7%) 0.710
NYHA (1–4) 2.6 ± 0.7 2.2 ± 1.0 0.228
Euro SCORE 4.8 ± 2.0 3.8 ± 2.4 0.037
Prior cardiac surgery
MVP 5 (50.0%) 9 (33.3%) 0.454
CABG 3 (30.0%) 1 (3.7%) 0.052
MVR 0 (0%) 5 (18.5%) 0.295
AVR 1 (10.0%) 3 (11.1%) 1.000
Redo MVR 1 (10.0%) 1 (3.7%) 0.473
Congenital cardiac surgery 0 (0%) 4 (14.8%) 0.557
Complex valve surgery 0 (0%) 3 (11.1%) 0.548
Bentall procedure 0 (0%) 1 (3.7%) 1.000
BSA, body surface area; LVEF, left ventricular ejection fraction; PAP,
pulmonary artery.
pressure; Dd, dimension diastolic; Ds, dimension systolic; LAD, left atrial
dimension; MR.
mitral regurgitation; AF, atrial fibrillation; NYHA, New York Heart Association; MVP.
mitral valve plasty; CABG, coronary artery bypass grafting; MVR, mitral
valve replacement;
AVR, aortic valve replacement.high-risk of median sternotomy approach, such as pa-
tients with patent bypassed graft, healed mediastinitis
and broad adhesions between sternum and right ven-
tricle or innominate vein. Additionally, as the proced-
ure required right thoracotomy, one-lung ventilation
and femoral-femoral cardiopulmonary bypass, we had
needs to consider these factors.
The mean age was not significantly different (Group I:
68 ± 15 years versus Group II: 62 ± 15 years; p = 0.217),
and the mean body surface area was also not significantly
different (Group I: 1.54 ± 0.29 m [2] versus Group II:
1.57 ± 0.18 m [2]; p = 0.411). There were significant dif-
ferences in preoperative left ventricular ejection fraction
(LVEF), left ventricular diastolic dimension (LVDd) and
LV systolic dimension (LVDs). The LVDd and LVDs in
Group I were significantly larger (57.0 ± 8.7 mm and
42.3 ± 15.2 mm in Group I versus 48.2 ± 6.7 mm and
30.6 ± 5.9 mm in Group II; p = 0.009 and = 0.009, re-
spectively). The LVEF in Group I was significantly
lower compared to Group II (Group I: 50.5 ± 19.8% ver-
sus Group II: 64.4 ± 12.0%; p = 0.046). Additionally, lar-
ger amount of preoperative mitral regurgitation was
revealed in Group I (Group I: 3.9 ± 0.2 versus Group II:
3.1 ± 1.1; p = 0.046). Though the preoperative pulmonary
artery pressure New York Heart Association (NYHA)
classification was not significantly different, significantly
higher Euro SCORE was found in Group I (Group I:
4.8 ± 2.0 versus Group II: 3.8 ± 2.4; p = 0.037).
In Group I, previous surgery included mitral valvuloplasty
(MVP) in 4 patients, coronary artery bypass grafting
(CABG) in 2 patients, redo MVR in one patient, aortic
valve replacement (AVR) in one patient, mediastinitis after
MVP in one patient, and CABG with Bland-White-Garland
syndrome in one patient [7]. In Group II, previous surgery
included MVP in 9 patients, MVR in 5 patients, congenital
cardiac surgery in 4 patients, AVR in 3 patients, complex
valve surgery 3 patients, redo MVR in one patient, CABG
in one patient, and Bentall procedure in one patient.
Statistical analysis
Continuous data were presented as mean ± standard de-
viation, and were analyzed using a Mann–Whitney test
for independent data and a Wilcoxon signed rank test
for paired data as appropriate. Categorical variables are
given as a count and percentage of patients and com-
pared using χ-square or Fisher’s exact test. A probability
value of less than 0.05 was considered significant. All
data were analyzed using the Statistical Analysis Systems
software JMP 9.0 (SAS Institute Inc. Cary, NC, USA).
Surgical technique
Reoperative MVR under VF through right mini-thoracotomy
After intubation with a double lumen endotracheal tube,
transesophageal echocardiography was used for cardiac






Operative time (min) 262 ± 46 300 ± 57 0.044
CPB time (min) 145 ± 25 135 ± 28 0.281
Cross-clamp time (min) 84 ± 19 0.120
VF time (min) 90 ± 7
Reperfusion time after
declamp (min)
27 ± 8 0.038
after cardioversion (min) 33 ± 8
Minimum BT (°C) 27.7 ± 1.4 33.7 ± 1.5 < 0.0001
Inotropic agent support 2 (20.0%) 6 (22.2%) 1.000
Maximum CK 740.8 ± 436.4 591.5 ± 452.3 0.266
CK-MB (IU/L) 35.0 ± 10.7 60.5 ± 64.9 0.155
Maximum GOT (IU/L) 77.0 ± 17.5 80.7 ± 50.3 0.320
CPB, cardiopulmonary bypass; VF, ventricular fibrillation; BT, body temperature;
CK, creatine.
kinase; GOT, glutamic oxaloacetic transaminase.
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thoracotomy (skin incision ≤ 10 cm) under one lung
ventilation at the 4th anterolateral intercostal space. The
endoscopic port was placed at the right 5th anterior
intercostal space and used as a CO2 port. Intracardiac
operation was performed under three-dimensional
videoscope support. An arterial catheter was inserted
from the right femoral artery, and venous cannulae were
placed through the right femoral vein and the right in-
ternal jugular vein. In elderly patients, axillary artery
could be used for arterial cannulation. Cardiopulmonary
bypass was then instituted using a system for vacuum-
assisted venous drainage. The pericardium was opened
vertically, just 1cm medial to the right phrenic nerve.
Left atrial venting was initiated through the right upper
pulmonary vein. After cooling to 27–30°C, MVR was
performed by conventional left atriotomy under VF. In-
tracardiac operation was performed using instruments
for minimally invasive mitral surgery under video sup-
port. After a prosthetic valve was sewn into place in
standard fashion, the left atriotomy was closed with
opening the prosthetic valve by inserting a rubber cath-
eter through the valve to left ventricle for de-airing. The
de-airing and rewarming was completed, and cardiover-
sion was performed. After recovery to normal sinus
rhythm, cardiopulmonary bypass was terminated and
the femoral cannulae were removed. A right pleural
chest tube was positioned, and the incision was closed.
Reoperative MVR under cardiac arrest through median
sternotomy
Cardiopulmonary bypass (CPB) was standing by and the
chest was opened through median sternotomy. An arter-
ial catheter was inserted from the right femoral artery,
and venous cannula was placed through the right fem-
oral vein. After another venous cannula was placed
through the superior vena cava and CPB was established,
we performed dissection of adhesion to apex. Cardiac
arrest was achieved by using ascending aorta clamping




Average operative time was significantly shorter in
Group I (262 ± 46 min versus 300 ± 57 min; p = 0.044).
CPB times, average VF times in Group I and aortic
cross-clamp times in Groups II were equivalent. The
mean of reperfusion times after cardioversion in Group I
was longer than the mean of reperfusion times after
declamp in Group II (Group I: 33 ± 8 minutes versus
Group II: 27 ± 8 minutes; p = 0.038). The average of
intraoperative minimum body temperature were 27.7 ±
1.4°C in Group I and 33.7 ± 1.5°C in Group II. Therewere no significant differences in the average of postop-
erative maximum creatine kinase (CK), CK-MB and glu-
tamic oxaloacetic transaminase (GOT). There was no
case with requiring intra-aortic balloon pumping in both
groups. The perioperative data of the two groups are
shown in Table 2.
Postoperative variables
In-hospital mortality was 0/10 (0%) and 1/27 (3.7%) for
Groups I and II. Cause of death in Group II was sepsis.
Postoperative paravalvular leakage and late cardiac tam-
ponade occurred in 0/10 (0%) and 1/27 (3.7%), and stroke
occurred in 1/10 (10%) and 1/27 (3.7%) for Groups I and
II. The patient with stroke in Group I had cerebellar
hemorrhage requiring emergent craniotomy at 6 days
after operation. After the operation, the patient recovered
well. Although 2 patients underwent reoperation for
bleeding in Group II, there was no reoperation for bleed-
ing in Group I. New onset atrial fibrillation occurred in
0/10 (0%) and 3/27 (11.1%) for Groups I and II. There
was no significant difference of average times of postop-
erative ventilation, and postoperative hospital stay (7.6 ±
4.2 hours in Group I versus 17.8 ± 33.7 hours in Group II;
p = 0.700 and 18.3 ± 8.4 days in Group I versus 21.5 ± 13.2
days in Group II; p = 0.537). Intensive care unit (ICU) stay
in Group I was significantly shorter than Group II (1.8 ±
0.6 days in Group I, 3.0 ± 1.7 days in Group II; p = 0.025).
Although postoperative LVEF was lower in Group I
(Group I: 46.5 ± 18.6% versus Group II: 64.3 ± 8.8%; p =
0.004), postoperative NYHA classification was equivalent
(Group I: 1.3 ± 0.5% versus Group II: 1.3 ± 0.7%; p = 0.840).
There were no significant differences in improvement rate
of cardiac function. Table 3 compares the two groups
regarding postoperative variables.








7.6 ± 4.2 17.8 ± 33.7 0.700
ICU stay (days) 1.8 ± 0.6 3.0 ± 1.7 0.025
Postoperative hospital stay (days) 18.3 ± 8.4 21.5 ± 13.2 0.537
LVEF (%) 46.5 ± 18.6 64.3 ± 8.8 0.004
LVDd (mm) 51.0 ± 14.2 46.2 ± 5.5 0.545
LVDs (mm) 38.9 ± 15.3 29.8 ± 5.0 0.050
Change rate of LVEF (%) −8.7 ± 28.1 3.7 ± 18.0 0.184
Change rate of LVDd (mm) −11.8 ± 12.1 −3.4 ± 11.0 0.067
Change rate of LVDs (mm) −8.7 ± 12.3 −2.2 ± 13.3 0.198
NYHA (1–4) 1.3 ± 0.5 1.3 ± 0.7 0.840
Complications
Death 0 (0%) 1 (3.7%) 1.000
Paravalvular leakage 0 (0%) 1 (3.7%) 1.000
Stroke 1 (10.0%) 1 (3.7%) 0.473
Late cardiac tamponade 0 (0%) 1 (3.7%) 1.000
Reoperation for bleeding 0 (0%) 2 (7.4%) 1.000
New onset AF 0 (0%) 3 (11.1%) 0.548
ICU, intensive care unit; LVEF, left ventricular ejection fraction; NYHA, New
York Heart.
Association; AF, atrial fibrillation.
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Conventional reoperative MVR has several challenges
and difficulties. In a detailed review of the STS database,
it was demonstrated that the risk of mortality for iso-
lated MVR increased from 5.09% to 9.25% in the pres-
ence of a previous cardiac operation [8]. These findings
were confirmed in a more recent review of the same
database that demonstrated that reoperation was associ-
ated with significantly increased mortality for all valve
operations [9]. Division of the sternum carries an in-
creased risk of injury of major cardiac structures in the
presence of adhesions with the right ventricle, innom-
inate vein and bypassed grafts [10]. Thus, the injury
can be a cause of surgical mortality. Additionally, the
conventional approach requires dissection of broad ad-
hesions to the apex, aortic clamp and myocardial pro-
tection. In the case that requires mitral valve surgery
after deep sternal wound infection, we have no other
choice to avoid conventional approach through median
sternotomy [11].
Recently, minimally invasive cardiac surgery (MICS)
for mitral valve surgery has been developed. MICS was
associated with a mortality rate similar to that for open
sternotomy cases, reduced length of intensive care unit
and hospital stays, fewer blood transfusions, and a faster
return to normality compared with conventional opera-
tive approaches [12,13]. Similarly, Yamada and colleaguesreported that MICS was associated with earlier recovery
of daily activities and improved quality of life in the early
perioperative period [14]. Right mini-thoracotomy ap-
proach for mitral valve has been established and applied
to mitral valve reoperation [1,3-5]. Port-access technique
with thoracoscopic support for initial and reoperative mi-
tral valve surgery is also safe and effective [5,15-17]. We
introduced mini-thorocotomy approach into mitral valve
surgery from 2005, and 156 cases of minimally invasive
mitral valve surgery were performed. We also applied
this technique to reoperative mitral valve surgery and
selected non-clamp procedure under VF and mild
hypothermia. Right mini-thoracotomy approach can
achieve excellent operative view for the mitral valve with-
out dissection of adhesions to the apex. Additionally, we
used three-dimensional videoscope to optimally visualize
the mitral valve, as the efficiency has been reported
[18,19]. The procedure under VF does not require dissec-
tion of adhesions around the ascending aorta and can
avoid several difficulties regarding aortic clamp and myo-
cardial protection. As compared to mitral valve surgery
with cardioplegic arrest, the efficiency and safety of this
combination have been reported [6]. Our combination of
right mini-thoracotomy, non-clamp under VF and three-
dimensional videoscope support for reoperative mitral
valve surgery suggests the similar conclusion. Although
intraoperative myocardial protection is a major concern,
the safety of mitral valve surgery under VF through right
thoracotomy in the cases after CABG with functioning
internal mammary artery grafts has been reported [2,20].
In our study, although Group I required cooling and
rewarming time, average CPB times were equivalent
to Group II. The operation time in Group I was
shorter than Group II, and the process of operation
was very smooth in Group I. The average of postoper-
ative maximum CK, CK-MB and GOT were not sig-
nificantly different, and the lower preoperative EF and
larger amount of preoperative mitral regurgitation in
Group I had no effect on the operation. These data
demonstrated intraoperative myocardial protection
under mild hypothermia and VF was not an inappro-
priate myocardial protection strategy compared to
cardiac arrest with cardioplegic solution. As there was
no hospital mortality, postoperative paravalvular leak-
age, and reoperation for bleeding in Group I, the risk
of complications was lower compared to Group II.
The stroke occurred in Group I was not due to
thromboembolism or arterial cannulation, but small
cerebral aneurysm. Although there was no significant
difference of average times of postoperative ventilation,
and postoperative hospital stay, ICU stay in Group I
was significantly shorter than Group II. Moreover, al-
though preoperative Euro SCORE in Group I was sig-
nificantly higher, postoperative course in Group I were
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results suggest that reoperative MVR under VF through
right mini-thoracotomy is a reasonable alternative to
redo sternotomy for patients with previous sternotomy.
This study has several limitations. First of all, this
study was not a randomized study, and the number of
patients of cohort was small to prove the efficacy of this
procedure. Secondly, pathological data of myocardium
was not obtained and we cannot evaluate the damage of
myocardium histogenetically. Finally, these procedures
were performed by two different surgeons, and the bias
cannot be denied.
Conclusions
This early clinical experience suggests that the outcomes
of reoperative MVR under VF through right mini-
thoracotomy were acceptable as one of effective options
for patients who required reoperative mitral valve surgery.
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